A5001208649- Sinusitis and nasal conditions
- Head and Neck Surgical Oncology
- Asthma and respiratory diseases
- Drug-Induced Adverse Reactions
- Pituitary Gland Disorders and Treatments
- Allergic Rhinitis and Sensitization
- Nasal Surgery and Airway Studies
- Bone Tumor Diagnosis and Treatments
- Tracheal and airway disorders
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Head and Neck Anomalies
- Obstructive Sleep Apnea Research
- Oral and Craniofacial Lesions
- Cleft Lip and Palate Research
- Teratomas and Epidermoid Cysts
- Medical Imaging and Pathology Studies
- Tumors and Oncological Cases
- Mycobacterium research and diagnosis
- Cystic Fibrosis Research Advances
- Oral and Maxillofacial Pathology
- Salivary Gland Tumors Diagnosis and Treatment
- Cardiovascular and Diving-Related Complications
- Respiratory and Cough-Related Research
NorthShore University HealthSystem
2020-2023
University of Pennsylvania
2020-2022
Hospital of the University of Pennsylvania
2022
University of Chicago
2020-2022
University of Illinois Chicago
2017-2019
Illinois College
2017-2019
University of Illinois Urbana-Champaign
2017
Rush University
2014
Background Treatment of aspirin‐exacerbated respiratory disease (AERD) includes endoscopic sinus surgery (ESS) and aspirin desensitization (AD) with therapy after (ATAD). The objective this study was to determine the rate major complications associated use that resulted in discontinuation therapy. Methods This a retrospective chart review patients AERD who underwent ESS, AD, ATAD at single tertiary center between July 2016 February 2019. Complications were analyzed via analysis variance...
Background: Aspirin therapy and/or type 2 (T2) biologics are used in the management of aspirin-exacerbated respiratory disease (AERD). Objective: To identify number patients with AERD who tolerated aspirin therapy, yet due to persistent symptoms, incorporated T2 biologic management. Methods: A retrospective review was performed between July 2016 and June 2019. Patients underwent endoscopic sinus surgery (ESS), desensitization (AD), at least 6 months (ATAD) after AD, remained biologic-naive...
Abstract Objectives The use of topical corticosteroids to manage postoperative sinonasal symptoms after endoscopic skull base surgery (ESBS) has not been well studied. We quantified long‐term impact steroid irrigations (SIs) on quality life patients ESBS. Methods Retrospective review at the University Pennsylvania undergoing ESBS from 2010 2019. Data patient demographics and treatment with nasal saline irrigation twice daily without dissolved steroids (mometasone or budesonide) was...
Aspirin-exacerbated respiratory disease (AERD) is optimally managed by endoscopic sinus surgery (ESS) followed aspirin therapy after desensitization (ATAD). Most AERD quality of life (QOL) studies use the 22-item Sinonasal Outcomes Test (SNOT-22), which focuses predominantly on sinonasal outcomes.This study seeks to assess QOL outcomes in patients ESS and ATAD via 12-item Short Form Survey (SF-12), a well-validated measure for general health status chronic conditions.Retrospective review 112...
Aspirin-exacerbated respiratory disease (AERD) is an aggressive inflammatory disorder of the upper and lower tract. Corticosteroids, leukotriene modifiers, endoscopic sinus surgery (ESS), aspirin (ASA) desensitization, biological immunomodulators are currently used to treat disorder.The objective this study was determine psychosocial impact ESS ASA desensitization on AERD patients.All patients who underwent complete were divided into two cohorts based status. The metrics SNOT-22 collected...
Introduction: Postoperative care for endoscopic sinus surgery (ESS) often includes nasal saline and/or steroid irrigations to effectively control symptoms. Though topical corticosteroid use has been well characterized managing inflammatory diseases, their role in symptoms after ESS sinonasal tumors is unclear. We seek quantify the impact of postoperative on quality life patients with who have undergone ESS.
Introduction: Use of steroid irrigation in management chronic rhinosinusitis (CRS) after endoscopic sinus surgery (ESS) suggests improved outcomes.[1] However, literature regarding postoperative ESS for inverted papilloma (IP), is less clear.[2] Currently, there discrepancy on the usage nasal saline rinses versus optimizing long-term patient quality life (QoL) IP resection. This study analyzed post-operative outcomes to determine optimal with regard type patients IP.
Objectives: Inverted papilloma (IP) is a benign but locally destructive tumor in the sinonasal cavity. Treatment of IP consists surgical resection with endoscopic sinus surgery (ESS). Patients type II diabetes mellitus (DMII) are known to have systemic manifestations their disease, including poor wound healing after surgery. The Sinonasal Outcomes Test (SNOT-22) validated tool assess patient quality life and burden symptoms from disease. goal this study was compare postoperative life, based...
Objective: Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by the presence of both subjective and objective evidence sinonasal inflammation persisting for greater than 12 weeks. CRSwNP often associated development inverted papilloma (IP), which are benign, but locally destructive, tumors that may originate in cavity or paranasal sinuses. Surgical resection treatment choice IP. The role influencing quality life after surgical IP has not been previously elucidated. goal this...
Introduction: Sinonasal inverted papilloma (IP) is a benign but locally aggressive neoplasm. Diagnosis of IP consists computed tomography (CT) and nasal endoscopy findings while treatment surgical resection.[1] Lund Mackay (LM) scores are commonly used staging system to quantify severity sinus disease on CT imaging. It has been proposed that score ≥ 4 suggests higher probability for ≤ 3 lower disease.[2] Patients scoring greater than often candidates surgery.[3] The 22-question Outcome Test...
Objective: Inverted papilloma (IP) is a benign tumor that originates in the sinonasal tract and often locally aggressive. Treatment of IP consists surgical resection with endoscopic sinus surgery (ESS). Infection represents potential postoperative complication prophylactically managed systemic antibiotics. The goal this study to determine if addition antibiotic nasal irrigations medical regimen will improve patient quality life, as measured by Sinonasal Outcome Test (SNOT 22).